ABT Earnings Call Dip
Abbott is trading moderately lower on normal volume with low volatility, a pattern consistent with a measured post-earnings reaction as investors digest the third-quarter call, with the new SimpleScreen cancer screening launch providing a positive offset that keeps the selling orderly rather than sharp.
Sources: https://finance.yahoo.com/healthcare/articles
Sources
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works